The End of Alzheimer’s Program – Dale E. Bredesen, M.D. References

Following is a list of references from the book, The End of Alzheimer’s Program, published by Avery/Random House. Due to the length of the text, these references could not be included in the print version, and therefore are listed below. 

15 – Kathryn Richardson et al., BMJ 2019, 367, October 2019

Anticholinergic Drugs and Risk of Dementia: Case-Control Study

16 – Eduardo Ferracioli-Oda, Ahmad Qawasmi, and Michael H. Bloch, PLoS One 8, no. 5, e63773, May 2013

Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders

16 – Esmée M. S. Vural, Barbara C. van Munster, Sophia E. de Rooij, Drugs and Aging 31, no. 6, 441–51, May 2014

Optimal Dosages for Melatonin Supplementation Therapy in Older Adults: A Systematic Review of Current Literature

16 – Kamila Weissová et al., PLoS One 11, no. 1, e0146200, January 2016

Moderate Changes in the Circadian System of Alzheimer’s Disease Patients Detected in Their Home Environment

17 – Yu-Hang Gong et al., Journal of Pharmacy and Pharmacology 70, no. 1, 70–80, January 2018

Melatonin Ameliorates Aβ1-42-Induced Alzheimer’s Cognitive Deficits in Mouse Model

18 – Trisha A. Jenkins et al., Nutrients 8, no. 1, 56, January 2016

Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis

19 – Beatriz Calvo-Flores Guzman et al., Journal of Neurochemistry 146, no. 6, 649–69, April 2018

The GABAergic System as a Therapeutic Target for Alzheimer’s Disease

20 – Behnood Abbasi et al., Journal of Research in Medical Sciences 17, no. 12, 1161–69, December 2012

The Effect of Magnesium Supplementation on Primary Insomnia in Elderly: A Double-Blind Placebo-Controlled Clinical Trial

21 – Guosong Liu et al., Journal of Alzheimer’s Disease 49, no. 4, 971–90, August 2016

Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial

22 – Morgan A. Pratte et al., Journal of Alternative and Complementary Medicine 20, no. 12, 901–08, December 2014

An Alternative Treatment for Anxiety: A Systematic Review of Human Trial Results Reported for the Ayurvedic Herb Ashwagandha (Withania Somnifera)